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Abstract Necrotizing fasciitis is a rapidly progressive
infection and is a necrosis of the fascia and surrounding
tissues. Despite recent advances in its management, out-
comes have not improved and mortality rate is still high.
Between September 2007 and August 2009, we prospec-
tively studied twenty-four histopathologically proven nec-
rotizing fasciitis patients to assess the prognostic factors
that indicate the outcome. Mortality rate was 20.8%.
Twelve patients (50%) improved, while seven patients
(29.2%) were complicated by limb loss. Mortality rates
related to upper and lower limb involvement were similar
(20% vs. 22.2%). The rates of gangrene and amputation in
patients with diabetes mellitus were signiﬁcantly higher
than other comorbidities. Patients with gram-positive
infections had signiﬁcantly lower rates of amputation
(15.4% vs. 54.5%, P = 0.04). Mean band cell count and
serum potassium level were signiﬁcantly higher in the
nonsurvivors same as leukocyte count in the patients with
gangrene, while serum sodium level was signiﬁcantly
lower in nonsurvivors. We conclude that hyponatremia,
hyperkalemia, and increased band cells in the peripheral
blood of patients may be useful parameters in distin-
guishing life-threatening necrotizing fasciitis; hence, we
recommended lower threshold to amputation during sur-
gery for this group of patients.
Keywords Necrotizing fasciitis  Skin diseases,
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Introduction
Necrotizing fasciitis is an uncommon soft tissue infection
characterized by extensive rapidly progressive necrosis of
the fascia and subcutaneous tissues. It has a high rate of
mortality ranging from 6 to 76%. Clinical presentations can
be indolent or fulminant [1]. Risk factors include diabetes
mellitus, advanced age, obesity, liver disease, malignancy,
alcoholism, or other immunosuppressive disorders. In
recent years, an increased incidence has been attributed to
the intravenous drug abuse [2]. Initial signs and symptoms
are nonspeciﬁc including erythema, pain, edema, fever,
crepitus, and induration [3]. However, the differential
diagnosis has a wide spectrum. The bacterial etiology is
often polymicrobial. The most common organism is Group
A streptococcus, which can implicated in otherwise healthy
individuals. Other microorganisms include staphylococcus,
peptostreptococcus, bacteroid, and clostridium [4, 5]. In
spite of recent progress in the treatment methods, the
outcome has not improved and mortality rate is still high.
Orthopedic surgeons are often involved in the management
of patients with necrotizing fasciitis; hence, they should be
aware of the presentation and management of this life-
threatening condition.
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nostic, therapeutic, and prognostic aspects of the necro-
tizing fasciitis of the extremities.
Materials and methods
After receiving institutional review board approval and
informed consent from individual patients, 24 consecutive
patients who were managed for necrotizing fasciitis of the
extremities were recruited to this study. Treatment was
provided at a university hospital between September 2007
and August 2009.
There were 27 cases with primary diagnosis of necro-
tizing fasciitis, but three of them were not proven histopa-
thologically; hence, these cases were excluded from the
study. The study group consisted of consecutive patients
with necrotizing fasciitis of the extremities that was diag-
nosed clinically and conﬁrmed with histopathologic study.
Management of the patients was performed according to the
existing standard protocols. Primary diagnosis was made
according to the clinical characteristics of necrotizing fas-
ciitis (Table 1)[ 4]. Empirical antibiotic therapy was
administered according to the recommendation of a spe-
cialist in infectious diseases, which might be changed later
on the outcome of culture results. Debridement was per-
formed as soon as possible. Surgical exploration was carried
out for suspicious cases for both diagnostic and therapeutic
purposes. During exploration, the presence of fascial
necrosis and myonecrosis (dusky gray subcutaneous fat and
fascia with a scanty serosanguineous discharge), lack of
resistance to blunt dissection of the normally adherent
superﬁcial fascia, lack of bleeding, and the presence of foul-
smelling pus were indicative of necrotizing infection. All
necrotic tissues were debrided, and culture obtained from
the area of worst affected. All affected components
including subcutaneous tissue, fascia, and muscles were
removed and sent for histopathologic diagnosis of necro-
tizing fasciitis to include in the study. The wound was left
open, and the patient was taken to the operating room again
for inspection and further debridement every 24–48 h
depending on the appearance of the wound. After removing
all necrotic tissues and when the infection was under control
with a healthy granulating tissue growth, wound closure
with direct suture, skin graft, or ﬂaps was done. Tissue
biopsy specimen was prepared for all of the patients.
Amputation was performed for the patients who had
ascending infections not being controlled by repeated
debridement, exposed joints after initial debridement, and
severe sepsis. Early amputations in these patients were
preferred to control the septic foci in order to reduce the
number of surgical debridements and consequently, the
risks associated with each anesthetic procedure. Data were
collected through a questionnaire and include demograph-
ics, associated diseases, culture results, laboratory studies,
received treatments, and ﬁnal outcome. Only histopatho-
logically conﬁrmed cases (all of 24 patients) were included
in the study. The patients were followed for the outcome
including improvement, limb loss, or death. Improvement
was deﬁned as removal of necrotic tissue, control of
infection, and proper soft tissue coverage of the affected
limb that led to a viable limb. Survivors were the patients
who recovered from the disease either with improvement or
after amputation, whereas nonsurvivors were the patients
who died as a result of the disease. Data analysis was per-
formed using SPSS software version 11.5. The statistical
methods used to compare groups were chi-square test and t-
test (independent samples test).
Results
Twenty-four patients (18 men and 6 women) with histop-
athologically proven diagnosis of necrotizing fasciitis of
the extremities were included in the study. The mean age
(±SD) was 49.5 ± 16.1 years. Fifteen patients had lower
limb infection, and others had upper limb infection. Med-
ian time from the appearance of symptoms to the diagnosis
was 15 days (interquartile range: 7–27.25) and from the
primary diagnosis to the surgical treatment was 1.5 days
(interquartile range: 0–3).The difference between survivors
(either improved or amputated patients) and nonsurvivors
regarding the time from primary diagnosis to surgical
intervention was not statistically signiﬁcant. Twenty
patients (83.3%) had fever, and two patients (8.3%) pre-
sented with confusion.
Table 2 shows local ﬁndings at the site of infection in
our patients. Comorbidities are listed in Table 3. Twelve
patients (50%) improved, seven patients (29.2%) were
complicated by limb loss and none of them died (in two
patients, amputation was done during the ﬁrst surgical
debridement and in ﬁve patients during later debridement),
and 5 patients (20.8%) died during management of the
disease (Fig. 1). There was no signiﬁcant relation between
the mortality rate and local symptoms of the patients.
Table 1 Clinical characteristics of necrotizing fasciitis
Stage Features
I (early) Erythema, swelling, warmth, tenderness, fever
II
(intermediate)
Blister and bullae, skin ﬂuctuance, skin induration
III (late) Hemorrhagic bullae, skin hyposensitivity or
anesthesia, crepitation, tissue necrosis
progressing to gangrene
Wong and Wang [17]
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limb involvement were similar (22.2% vs. 20%, P[0.05),
whereas the lower limb infection had the higher rate of
amputation, in which this difference was statistically sig-
niﬁcant (40% vs. 11.1%).
Rate of gangrene was signiﬁcantly higher in patients
with diabetes mellitus (71.4% for those who had diabetes
mellitus vs. 23.5% for others, P = 0.02), but we found no
association between gangrene and other comorbidities. The
rate of limb loss was also signiﬁcantly higher in diabetic
cases [71.4% of diabetic patients suffered from amputation
vs. 15.4% of nondiabetics (P = 0.012) (Graph 1)].
Improvement in diabetic patients was signiﬁcantly lower
than in nondiabetics (14.3% vs. 64.7%), (P[0.025).
The results of tissue cultures are listed in Table 4.
Mortality rate in patients affected by gram-positive cocci
and other organisms was 30.8 and 9.1%, respectively, but
this difference was not statistically signiﬁcant (P = 0.1).
Patients with gram-positive infections had signiﬁcantly
lower amputation rate (15.4% vs. 54.5%, P = 0.04).
Culture results were positive for gram-positive cocci in
14.3% diabetic patients versus 70.6% nondiabetics
(P = 0.012).
Mean (±SD) age of survivors and nonsurvivors was
55.4 ± 15.6 and 41 ± 13.8 years, respectively (95% CI of
the difference (-2.1 to 31), P = 0.08). Mortality rate was
not associated with sex (20% in women vs. 26.7% in men,
P[0.05). Additionally, there was no association between
the amputation and mortality rates.
The mean (±SD) age was 56 ± 20.2 years in patients
with gangrene of the extremities versus 45.7 ± 12.3 years
in other patients (mean difference = 10.2, 95% CI of the
difference (-3.4 to 23.9), P = 0.1).
Laboratory ﬁndings on hospital admission are shown in
Table 5. Mean band cell count and mean serum potassium
level was higher in nonsurvivors compared with survivors
on hospital admission and this was statistically signiﬁcant
(68.3% vs. 24%, P = 0.08 and 4.7 meq/l vs. 3.9 meq/l, P =
0.03 respectively) at the time of admission (127.7 meq/l vs.
134.3 meq/l P = 0.008). Moreover, mean WBC count was
highest in the patients admitted with gangrene of the limb
(20 9 10
3/ll vs. 14 9 10
3/ll) which was statistically sig-
niﬁcant (P = 0.02).
Discussion
Necrotizing fasciitis was ﬁrst described in 1848. The
incidence has been reported in 0.4–0.53 cases per 100,000
in the United States [4, 5]. There may be an increased
incidence in Asian and African countries. A high index of
suspicion is required for the diagnosis of necrotizing fas-
ciitis. The patient may present only with pain, erythema,
and some swelling, so the disease is often mistaken as
cellulitis. Necrotizing fasciitis can often progress within a
few hours, and rapid progression of the erythema and
induration in spite of treatment with broad-spectrum anti-
biotic is an important diagnostic clue [4].
Anaya et al. [6] estimated that extremities were the most
common site of necrotizing fasciitis in 57.8% followed by
the abdomen and perineum. It is an invasive and
Table 2 Clinical characteristics of the infection site
Variable No. of cases (%) Survivors (%) Nonsurvivors (%)
Warmth 19 (79.2) 11 (57.9) 5 (100)
Erythema 16 (66.7) 8 (42.1) 5 (100)
Gangrene 9 (37.5) 7 (36.8) 1 (20)
Discharge 7 (29.2) 4 (21) 2 (40)
There were no statistically signiﬁcant difference between survivors
(N = 19) and nonsurvivors (N = 5)
Table 3 Incidence of preexisting conditions
Comorbidity No. of cases
(%)
Survivors
(%)
Nonsurvivors
(%)
Smoking 15 (62.5) 10 (52.6) 2 (40)
IV drug usage 11 (45.8) 7 (36.8) 2 (40)
DM 7 (29.2) 5 (26.3) 1 (20)
Renal disease 2 (8.3) 1 (5.2) 1 (20)
Malignancy 4 (16.7) 2 (10.5) 2 (40)
Peripheral vascular
disease
1(4.2) 1 (5.2) 0
HIV infection 4 (16.7) 2 (10.5) 2 (40)
Immunosuppression 3 (12.5) 2 (10.5) 0
There were no statistically signiﬁcant difference between survivors
(N = 19) and nonsurvivors (N = 5)
Fig. 1 Outcome of the patients
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123destructive infection that complicates the skin, subcutane-
ous tissue, deep fascia, and, to some extent, sparing of
muscle. General signs, such as fever and severe systemic
reactions, may be present.
Intramuscular injections and intravenous (IV) infusions
may lead to necrotizing fasciitis. In our series, 45.8% of the
cases were IV drug abusers. Angoules et al. [7] also
addressed drug abuse and needle punctures in the affected
site as the commonest cause of necrotizing fasciitis of
extremity, and drug abuse and needle punctures were found
in 129 (33%) patients in a systematic review of necrotizing
fasciitis of upper and lower limb.
Gonzalez et al. [8] have also reported a higher ampu-
tation rate in patients with polymicrobial, anaerobic, and
gram-negative infections. In our series, patients with gram-
positive infections had signiﬁcantly lower amputation
rates. It seems that higher amputation rate in diabetic
patients may be related to different organisms such as an-
aerobics or gram-negative infections.
Necrotizing fasciitis can be difﬁcult to recognize in
early stages, especially in patients with diabetes mellitus.
In this series, mean delay to diagnosis was considerably
higher in diabetic patients.
Although in our series delayed diagnosis or treatment
was not signiﬁcantly related to mortality rate, in some
studies, early diagnosis and immediate, radical surgery
improved the survival rate [9, 10].
Ogilvie and Miclau [11] showed that elevated serum
potassium is a relative mortality risk factor (relative risk
(95% CI) = 5.40 (1.90–15.3)) and mean serum potassium
in nonsurvivors and survivors was 4.6 mmol/l versus
3.9 mmol/l, respectively. In our patients, same results for
diabetics nondiabetics
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Graph 1 Rate of amputation in patients according to diabetes
mellitus
Table 4 Tissue culture results
Culture result No. of cases
(%)
Survivors
(%)
Nonsurvivors
(%)
Acinetobacter 3 (12.5) 2 (10.5) 0
Enterobacter 3 (12.5) 7 (36.8) 4 (80)
Gram-positive
cocci
13 (54.1) 3 (15.7) 0
Polymicrobial 5 (20.8) 3 (15.7) 1 (20)
There were no statistically signiﬁcant difference between survivors
(N = 19) and nonsurvivors (N = 5)
Table 5 Mean (±SD) of
laboratory ﬁndings on hospital
admission
WBC white blood cell; PT
prothrombin time; PTT partial
thromboplastin time; AST
aspartate aminotransferase; ALT
alanine aminotransferase; BUN
blood urea nitrogen
*P value\0.05
Variable Overall Survivors Nonsurvivors Normal
WBC count 9 10
3/mm
3 16.29 ± 6.3 15.8 ± 6.2 20.2 ± 7.9 4.5–11
Band cell (%)* 32 ± 27.6 24 ± 19.5 68.3 ± 29 3–5
Platelet 9 10
3/mm
3 230.2 ± 112.2 233.4 ± 119 175.8 ± 88 150–400
PT (s) 16 ± 1.8 16 ± 1.8 16 ± 1.6 11–13.5
PTT (s) 36.5 ± 8.8 37 ± 9.5 40 ± 5 25–35
Serum protein (g/dl) 4.7 ± 0.58 4.8 ± 0.5 4.4 ± 0.5 6–8
Serum albumin (g/dl) 3.1 ± 0.66 3.3 ± 0.39 3.3 ± 0.58 3.5–5.5
Alk-p (IU/l) 228.8 ± 146.1 202 ± 144 269 ± 115 35–150
ALT (IU/l) 52.5 ± 38.9 42.6 ± 14.3 40.2 ± 20.6 1–45
AST (IU/l) 56.1 ± 29.4 50.7 ± 21.6 50 ± 25.6 1–36
BUN (mg/dl) 47.5 ± 22.2 42.9 ± 18.9 55.5 ± 28.3 11–23
Cr (mg/dl) 1.13 ± 0.37 1.1 ± 0.2 1.3 ± 0.69 0.6–1.2
Sodium (meq/l)* 132.8 ± 3.3 134 ± 2.4 127.7 ± 2.6 135–145
Potassium (meq/l)* 4 ± 0.63 3.9 ± 0.54 4.7 ± 0.7 3.5–5
Calcium (mg/dl) 8.8 ± 0.7 8.9 ± 0.4 9.1 ± 1.1 8.4–10.6
Blood pH 7.41 ± 0.07 7.4 ± 0.04 7.38 ± 0.12 7.35–7.45
Bicarbonate (meq/l) 21.9 ± 4.3 22.2 ± 3 17.6 ± 4.8 21–27
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123mean serum potassium were found (4.7 in nonsurvivors vs.
3.9 in survivors). In addition, in our series, mean serum
sodium was signiﬁcantly lower in nonsurvivors (mean:
127.7). These ﬁndings may represent renal dysfunction due
to multiorgan damage caused by more severe infection and
also hyponatremia that may be due to ﬂuid sequestration in
more severe soft tissue infections. So hyponatremia and
hyperkalemia may be useful parameters in distinguishing
life-threatening necrotizing fasciitis, which may suggest
more aggressive management in these groups of patients.
Hsieh compared platelet counts in patients with necro-
tizing fasciitis and in patients with cellulitis and found
lower platelet counts in the ﬁrst group (mean: 194.0 9 10
9/
l vs. 299.3 9 10
9/l P = 0.03) [12], but such relationship
has not been found in our study.
According to the literature, mortality rate resulting from
necrotizing fasciitis ranges from 9.3 to 76% [13]. Callahan
et al. [14] performed a meta-analysis of 14 studies and
assigned an overall mortality rate of 26%. Pessa and
Howard [15] also demonstrated a mortality rate of 18% in
extremity infection compared with 44 and 33% in
abdominal and perineal infections, respectively. In our
series, the overall mortality rate was 20.8%, and mortality
rates in patients with upper and lower limb infection were
22.2 and 20%, respectively. In our series, the risk of
amputation was signiﬁcantly higher in lower limb
involvement, but survival rate in upper or lower limb
involvement was not signiﬁcantly different.
Aggressive treatment of the patient with suspected
necrotizing fasciitis can reduce morbidity and mortality
rate [16]. Treatment should be initiated as soon as a nec-
rotizing soft tissue infection is suspected and should
include broad-spectrum antibiotics, resuscitation, early
debridement, and early second surgical exploration [8]. In
our series, we did early amputation as the ﬁrst surgical
intervention in two cases, which was life saving for them.
This study can highlight the importance of early recogni-
tion of mortality risk factors and decision for early ampu-
tation as a life saving surgical procedure in this group of
patients with necrotizing fasciitis.
According to our ﬁndings at the time of admission, the
presence of hyponatremia, hyperkalemia, and increased
band cell count in peripheral blood are risk factors for
mortality, and the presence of diabetes mellitus increased
the risk of amputation in lower limbs. So, lower threshold
to amputation may be mandatory in this group of patients.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution and reproduction in any medium, provided the original
author(s) and source are credited.
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